Report Overview

2023

Base Year

2018-2023

Historical Year

2024-2032

Forecast Year

Global Liver Cancer Therapeutics Market Trends

Cancer is a life-threatening disease where the cells of a part of our body go out of control and starts growing rapidly. This disease, when effects and starts growing in the liver, is known as liver cancer or hepatic cancer. Although early signs of liver cancer are usually non-existent, they may include unconditional weight loss, appetite loss, upper abdominal pain, nausea, and vomiting, abdominal swelling, jaundice, general weakness and fatigue.

 

  • The rising prevalence of liver cancer diseases is a major factor propelling market growth. People around the world are increasingly adopting a sedentary and unhealthy lifestyle, with increased consumption of alcohol and tobacco. These are very injurious for the liver and are the primary factor to aid liver cancer therapeutics market development.
  • Market players are developing a sturdy drug pipeline that can aid cancer research and development. This will help in the development of new treatments with combination therapy that can provide enhanced treatment to the patients.
  • Market players and institutions are increasingly engaging in research and development activities to develop novel medicines and improve the treatment of cancer through therapeutic drugs, which can extend the patients' lifespan. The availability of improved therapeutic options can significantly help in market expansion.

 

Liver Cancer Therapeutics Market Report Snapshots

Liver Cancer Therapeutics Market Size

Liver Cancer Therapeutics Market Trends

Liver Cancer Therapeutics Market Analysis

Liver Cancer Therapeutics Companies

 

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*

Looking for specific insights?

Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!

Key Questions Answered in the Report

The market is expected to grow at a CAGR of 19.85% during the forecast period of 2024-2032.

The market is driven by the growing prevalence of liver cancer among people, especially the ageing population, around the world and the simultaneously rising demand for cancer therapeutics.

The increasing investment by market players and the government to introduce innovative solutions in the market and the rising demand for targeted therapy for cancer treatment can aid the market development.

The regional markets include North America, Europe, the Asia Pacific, Latin America, the Middle East and Africa.

The types of liver cancers found in people include hepatocellular carcinoma, cholangio carcinoma, and hepatoblastoma, among others.

The market provides various therapy types including ablation therapy, embolization therapy, radiation therapy, targeted therapy, immunotherapy, and chemotherapy.

The different services available in the market include oral and intravenous administration.

The different distribution channels available in the market include hospital pharmacies, retail pharmacies, and online pharmacies.

The key players in the market include Bayer AG, Bristol-Myers Squibb Company, Pfizer Inc., Exelixis, Inc., Merck & Co., Inc., Eli Lilly and Company, and F. Hoffmann-La Roche Ltd, among others.

Purchase Full Report

Datasheet

 

USD 2,969

USD 2,699

tax inclusive*

  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

One User

USD 5,499

USD 4,999

tax inclusive*

  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

Five Users

USD 6,599

USD 5,999

tax inclusive*

  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

Unlimited Users

USD 7,699

USD 6,999

tax inclusive*

  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

How To Order

Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.

Select License Type

Choose the right license for your needs and access rights.

Click on ‘Buy Now’

Add the report to your cart with one click and proceed to register.

Select Mode of Payment

Choose a payment option for a secure checkout. You will be redirected accordingly.

Strategic Solutions for Informed Decision-Making

Connect For More Information

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.

Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.

We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.

Back to top

We’re here to help answer any questions about our products and services.

Contact us

Our Offices


Australia

63 Fiona Drive, Tamworth, NSW

+61 448 06 17 27

India

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

Philippines

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.

+63 287899028, +63 967 048 3306

United Kingdom

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

United States (Head Office)

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

Vietnam

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84865399124

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

63 Fiona Drive, Tamworth, NSW

+61 448 06 17 27

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.

+63 287899028, +63 967 048 3306

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84865399124

$getforecastarray = array(); if (isset($ismapshow)) { $forecast_period_start = isset($forecast_period_start) ? $forecast_period_start : ''; if ($forecast_period_start != "") { $yearInc = 1; for ($startfrom = $forecast_period_start; $startfrom <= $forecast_period_end; $startfrom++) { $calculatFercastYear=calculateFutureValue(($getReportDetail['base_value']> 0) ? $getReportDetail['base_value'] : 100, $getReportDetail['cagr'], $yearInc); $getforecastarray[] = array('years' => "$startfrom", 'value' => $calculatFercastYear); $yearInc++; } } } $getforecastarrayJson = json_encode($getforecastarray); ?>